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Mesenchymal/Epithelial Induction
Mediates Olfactory Pathway Formation
inductive signals. These embryonic primordia undergo
changes consistent with mesenchymal/epithelial induc-
tion. The surface epithelium thickens and invaginates
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and Center for Neuroscience to form the olfactory pit (Jacobson, 1963; Cuschieri and
Bannister, 1975), the ventrolateral telencephalon thick-The University of North Carolina
at Chapel Hill, Medical School ens and invaginates to form the olfactory bulb (Hinds,
1968), and the mesenchyme condenses to form cartilageChapel Hill, North Carolina 27599
†National Institute for Neurological Diseases and bone in the nose (Richman and Tickle, 1989). In
addition, as is the case for the mesenchyme of the limbs,and Stroke
Betheseda, Maryland 20892 heart, and branchial arches (Le Lievre and Le Dourain,
1975; Rollhauser-ter Horst, 1975; Lumsden, 1988; Waldo
et al., 1996), neural crest contributes to the frontonasal
mesenchyme (Serbedzija et al., 1992; Osumi-YamashitaSummary
et al., 1994). Finally, there are several inductive signaling
molecules present in epithelia or mesenchyme of theIn the olfactory pathway, as in the limbs, branchial
arches, and heart, mesenchymal/epithelial induction, olfactory primordia. These include retinoic acid (RA),
fibroblast growth factor 8 (FGF8), sonic hedgehog (shh),mediated by retinoic acid (RA), FGF8, sonic hedgehog
(shh), and the BMPs, defines patterning, morphogene- and bone morphogenetic protein 4 (BMP4; Echelard et
al., 1993; LaMantia et al., 1993; Francis-West et al., 1994;sis, and differentiation. Neuronal differentiation in the
olfactory epithelium and directed growth of axons in Heikinheimo et al., 1994; Crossley and Martin, 1995).
While it is generally agreed that none of these factorsthe nascent olfactory nerve depend critically upon this
inductive interaction. When RA, FGF8, shh, or BMP act alone to mediate induction and differentiation (for
review see Johnson and Tabin, 1997), their availabilitysignaling is disrupted, distinct aspects of olfactory
pathway patterning and differentiation are compro- suggests that molecular signaling between epithelium
and mesenchyme can influence early olfactory pathwaymised. Thus, a cellular and molecular mechanism that
facilitates musculoskeletal and vascular development development.
Despite these suggestions, there is no evidence thatelsewhere in the embryo has been adapted to guide
the differentiation of the olfactory pathway in the de- mesenchymal/epithelial induction contributes to olfac-
tory pathway development. In fact, there is still contro-veloping forebrain.
versy over whether formation of the olfactory epithelium
and nerve relies upon cell migration from the neural tubeIntroduction
and long distance signals from the forebrain versus local
signals between epithelium and mesenchyme (reviewedFrom the earliest descriptions of neural development, a
mystery has confronted embryologists—are there tis- by Farbman, 1988, 1992). We therefore asked if there is
mesenchymal/epithelial induction in the nascent olfac-sue–tissue interactions that induce the differentiation of
forebrain regions and pathways? Unlike the spinal cord tory pathway. We found that induction mediated by local
molecular signals orchestrates axis formation, pat-and hindbrain where signals from the notochord, so-
mites, and dorsal ectoderm influence differentiation (re- terned gene expression, morphogenesis, and cellular
differentiation during the initial formation of the olfactoryviewed by Tanabe and Jessell, 1996), there is no known
source of inductive signals for specific forebrain subdivi- epithelium and nerve.
sions or related neural structures (reviewed by Lumsden
and Krumlauf, 1996; Rubenstein and Beachy, 1998). At Results
several embryonic sites outside the central nervous sys-
tem, including the limbs, branchial arches, and heart, Mesenchymal/Epithelial Apposition in the Frontonasal
induction between mesenchyme and adjacent epithelia Mass and Forebrain
underlies local axis formation, morphogenesis, and dif- We first defined the relationship between mesenchyme
ferentiation (reviewed by Tickle and Eichele, 1994; John- and epithelium in the primordial olfactory pathway. As
son and Tabin, 1997; Creazzo et al., 1998). We asked early as E8.0, there are distinct mesenchymal and epi-
whether a similar inductive mechanism between the thelial compartments in the frontonasal region (Figure
mesenchyme of the frontonasal mass and adjacent epi- 1A). A coherent mass of mesenchymal cells separates
thelia mediates differentiation of a major component of the surface epithelium of the head (which gives rise to
the forebrain—the olfactory pathway. the olfactory epithelium) and the forebrain neuroepithel-
As in the limbs, branchial arches, and heart, the sur- ium (which gives rise to the olfactory bulb). A subpopula-
face epithelium of the head, the frontonasal mesen- tion of neural crest–associated cells in the frontonasal
chyme, and the forebrain neuroepithelium are apposed mesenchyme can be visualized using a gene-trap mouse
to one another and thus are well positioned to exchange (the bgeo6 mouse) where b-galactosidase (b-gal) labels
cells in all targets of cranial neural crest including the
frontonasal region (Figures 1A and 1B). These cells can‡ To whom correspondence should be addressed (e-mail: anthony_
lamantia@med.unc.edu). be specifically double labeled by antibodies against nes-
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Figure 1. Mesenchymal/Epithelial Apposi-
tion in the Developing Olfactory Pathway
(A) Front view of an E8.5 bgeo6 embryo show-
ing b-galactosidase-labeled cells in the fron-
tonasal mesenchyme (m) between the fore-
brain (fb) and the lateral surface epithelium
of the head (se).
(B) At E 9.0 the bgeo6 locus is expressed in
the rudimentary fifth and eight cranial ganglia
(g5 and g8), as well as mesenchyme in the
first and second branchial arch (bI and bII),
maxillary process (mx), around the eye (e),
and frontonasal mass (arrows, fnm).
(C) Live image of an E9.0 isolated surface
epithelium showing no differentiation after 48
hr in culture.
(D) Live image of E9.0 frontonasal mesen-
chyme showing no differentiation after 48 hr
in culture.
(E) Live image of an explant where surface
epithelium and mesenchyme have been re-
combined. After 48 hr in culture, an epithelial
region thickens and invaginates (arrows).
There is also a single, distinct spherical mass
of cells at the periphery of the explant (as-
terisk).
(F) ROSA26 mesenchyme recombined with
wild-type epithelium. The mesenchyme is la-
beled by b-gal, reflecting its ROSA26 origin,
while the presumed olfactory pit (arrows) and
peripheral cell mass (asterisk) is unlabeled,
indicating that these cells come from the
wild-type epithelium.
tin, an established marker for neural crest in mammals are recombined, a distinct subregion of the epithelium
thickens, invaginates, and resembles the olfactory pit(Stemple and Anderson, 1992; data not shown), and
GAP43, also seen in crest derivatives (Benowitz et al., in intact E10.5/E11 embryos (Figure 1E; Table 1). In addi-
tion, there is a single spherical mass of cells at the1988; data not shown). Thus, a molecularly distinct pop-
ulation of neural crest–associated mesenchymal cells is periphery of the explant (Figure 1E, asterisk).
We then assessed whether morphogenesis dependsimmediately adjacent to cranial epithelia that give rise
to the olfactory pathway. upon cell–cell signaling versus cell migration between
mesenchyme and epithelia. We recombined wild-type
epithelium with mesenchyme from ROSA26 embryos inMesenchymal/Epithelial Interactions
and Morphogenesis which every cell is labeled by b-gal (Zambrowicz et al.,
1997). After 48 hr, the thickened epithelium consists ofTo determine if inductive interactions occur between
the frontonasal mesenchyme and epithelia, we cultured wild-type cells (i.e., unlabeled by b-gal; Figure 1F), while
the mesenchyme consists of ROSA26 cells. There is noundifferentiated surface epithelium and mesenchyme
from the frontonasal mass of E9.0 embryos separately detectable migration of mesenchymal cells into the pit-
like structure. There is, however, an apparent transloca-or recombined. We first assessed the morphogenetic
capacity of isolated or recombined tissues after 48 hr tion of epithelial cells through the mesenchyme. These
cells are seen in the peripheral cell mass at the explantin culture. Isolated epithelium remains a single-cell layer
and shows little cytological differentiation (Figure 1C). perimeter (Figure 1F, asterisk). Accordingly, apposition
of the frontonasal mesenchyme and surface epitheliumFrontonasal mesenchyme also remains an undifferenti-
ated cell mass (Figure 1D). In contrast, when the two leads to local epithelial differentiation and subsequent
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Table 1. Morphological Differentiation of Epithelial, Mesenchymal, and Recombined Cultures
Result
Type of Culture Differentiated (1) Undifferentiated (2) 1/2 Percent 1
Surface Epithelium 0 33 7 17.5%
Mesenchyme 0 16 3 15%
Recombined 29 2 6 78%
Morphological differentiation was assessed in 96 cultures from 9 litters of E9.0 embryos. After 48 hours in vitro, live images were evaluated.
To be scored as differentiated, the culture had to show a thickened and invaginated epithelial pit, a complete covering of epithelium, and
underlying mesenchymal mass. To be scored as undifferentiated, surface epithelial cultures had to show a single-cell-thick epithelial sheet,
and mesenchymal cultures had to show a coherent, undifferentiated cell mass. The 1/2 category included recombined cultures where the
presumptive olfactory epithelium had not completely invaginated or the mesenchyme was not completely covered by an overlying epithelium.
Surface epithelial cultures with small patches of thickened epithelial cells were assigned to this category, as were mesenchymal cultures with
any indication of nonuniform cell groups in the mesenchymal mass.
formation of an olfactory pit-like structure. This morpho- bined cultures, NCAM is seen in cells concentrated in
an epithelial subregion as well as in neurites that formgenesis must depend upon molecular signaling between
mesenchyme and epithelium since there is no indication bundles and coalesce into an apparent nerve in the
mesenchyme. In addition, NCAM labels the peripheralthat cells migrate between the two tissue compart-
ments. cell mass. These cells may be either the precursors of
GNRH neurons that migrate from the olfactory epithe-
lium along the olfactory nerve toward the brain (WrayMesenchymal/Epithelial Induction, Cellular and
et al., 1989; Schwanzel-Fukuda et al., 1992) or precur-Molecular Differentiation in the Olfactory Pathway
sors of ensheathing cells that will provide glial invest-We next asked whether mesenchymal/epithelial induc-
ment for mature olfactory axons (Doucette, 1990). NCAMtion in the olfactory primordia influences patterned ex-
is not seen in isolated epithelium or mesenchyme.pression of molecules associated with differentiation in
The transcription factor Pax-7 is expressed primarilythe olfactory pathway. The neuroblast marker b-tubulin
in the mesenchyme of the lateral nasal process, anddistinguishes the olfactory epithelium at midgestation
when this gene is inactivated, some lateral nasal struc-(Easter et al., 1993; Whitesides and LaMantia, 1996;
tures do not develop (Mansouri et al., 1996). Pax-7 isRoskams et al., 1998). b-tubulin cannot be detected
not detected in olfactory primordia at E9.0 (Figure 2,in the frontonasal region of E9.0 embryos from which
fourth column). At E10, however, prior to morphogenesisepithelium and mesenchyme are cultured (Figure 2, first
of the lateral nasal process, Pax-7 is seen in the lateralcolumn). Subsequently, at E10, b-tubulin is expressed
frontonasal mesenchyme. By E11, Pax-7 clearly distin-in a patch of surface epithelial cells. As the olfactory pit
guishes the lateral from the medial mesenchyme. In re-invaginates, b-tubulin defines the entire presumptive
combined cultures, Pax-7 is limited to mesenchyme onolfactory epithelium as well as the nascent olfactory
one side of the apparent olfactory epithelium but is notnerve. In recombined cultures, b-tubulin is expressed in
seen in the peripheral cell mass. Pax-7 is not detectedthe epithelial pit and the peripheral cell mass. b-tubulin is
in isolated epithelium or mesenchyme.not seen when the epithelium is cultured alone and is
Finally, we asked whether apparent regional distinc-occasionally expressed in scattered cells in the isolated
tions in neural and mesenchymal markers reflect axesmesenchyme.
that constrain olfactory pathway assembly. In the em-The retinoid synthesizing enzyme retinaldehyde dehy-
bryo, Pax-7 defines a medial–lateral boundary that ex-drogenase 2 (RALDH2) contributes to RA synthesis in
tends the entire anterior–posterior length of the fron-the developing nervous system (Zhao et al., 1996; Sock-
tonasal mesenchyme (Figures 3A and 3C). Pax-7 is alsoanathan and Jessell, 1998; Niederrethier et al., 1999),
seen in epithelial cells at the lateral margin of the nasalperhaps including the frontonasal region where RA is
pit (Figure 3E, arrowheads). NCAM-labeled cells are lim-locally available (LaMantia et al., 1993). RALDH2 is not
ited to the medial aspect of the invaginated olfactoryexpressed in the frontonasal mass at E9.0, although it
epithelium (Figures 3B, 3D, and 3E), and NCAM-labeledis present in the optic vesicle (Figure 2, second column).
axons follow the medial–lateral boundary defined bySubsequently, RALDH2 is seen in the lateral–posterior
Pax-7 expression (Figure 3E); however, they extend onlyfrontonasal process. A similar pattern is seen in recom-
toward the anterior pole of the forebrain (Figure 3D).bined epithelium and mesenchyme. RALDH2 is not ex-
These medial–lateral and anterior–posterior distinctionspressed in isolated epithelium; in contrast, it persists in
are maintained in vitro (Figure 3F).a central mass of isolated mesenchymal cells.
The neural cell adhesion molecule (NCAM) is diagnos-
tic for differentiating olfactory epithelial neurons in vivo Local Sources of Signaling Molecules
in the Developing Olfactory Pathwayand in vitro (Calof and Chikaraishi, 1989; Croucher and
Tickle, 1989; Miragall et al., 1989; Key and Akeson, 1990; We next explored whether specific molecular signals
from either the mesenchyme or epithelium are locallySchwanzel-Fukuda et al., 1992; Whitesides and LaMan-
tia, 1996; Shou et al., 1999). NCAM is not expressed in available to contribute to induction, axis formation, and
subsequent differentiation. We focused upon four sig-olfactory primordia at E9.0 (Figure 2, third column) but
delineates the epithelium and nerve by E11. In recom- nals—RA, FGF8, shh, and BMP4—each of which is
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Figure 2. Patterning and Differentiation in the Olfactory Pathway Depends upon Mesenchymal/Epithelial Apposition
In each column, labeling for a marker associated with cellular differentiation in the olfactory pathway is shown. Arrows in each panel indicate
either the olfactory primordia or the region within the olfactory primordia where the relevant molecule is expressed. The first three panels of
each column show the chronology and pattern of expression of each marker in embryos between E9.0 and E11.0—the times when cultures
are initiated and terminated. The last two panels of each column show the expression and pattern of these markers in recombined epithelial/
mesenchymal cultures, isolated epithelium, and mesenchyme (e or m, as indicated at bottom right of each panel).
thought to contribute to patterning and morphogenesis brain (Figures 4A and 4B). To evaluate whether the posi-
tion of crest cells is related to the local source of RA,in limbs (reviewed by Johnson and Tabin, 1997),
branchial arches (Helms et al., 1997; Francis-West et we cultured the frontonasal mass from E10.0 bgeo6
embryos, mesenchyme side down, on monolayers of anal., 1998), and heart (Laufer et al., 1994; Vogel et al.,
1996). RA indicator cell line (LaMantia et al., 1993) reengineered
with green fluorescent protein (GFP) as the reporter. InWe have previously established that the frontonasal
mesenchyme provides a local source of RA for the devel- these cocultures, we saw RA-activated GFP-expressing
indicator cells (in the monolayer underlying the explant)oping forebrain (LaMantia et al., 1993). The location of
neural crest–associated mesenchyme in the lateral fron- only beneath bgeo6-expressing mesenchymal cells in
the lateral aspect of the explant (Figures 4C and 4D).tonasal mass is in register with domains of RA-mediated
gene expression in the olfactory epithelium and fore- We confirmed this using mutant Pax-6Sey/Pax-6Sey (small
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Figure 3. Medial–Lateral and Anterior–Posterior Axes in the Developing Olfactory Pathway Depend upon Mesenchymal/Epithelial Inductive
Signaling
(A) Front view of an E10.5 embryo forebrain and frontonasal mass immunolabeled for Pax-7, showing the unlabeled medial nasal process
(mnp), the labeled lateral nasal process (lnp), and the olfactory pit (op) between the two. The white arrows indicate the border between the
Pax-7-labeled lateral and the unlabeled medial mesenchyme.
(B) Front view of an E10.5 embryo shows NCAM-labeled cells and axons in the olfactory epithelium and nerve. The black arrows indicate
NCAM-positive processes in the nerve, which follows the border between lateral and medial mesenchyme.
(C) The olfactory pit, dissected from an E10.5 embryo, viewed from above. The anterior pole is at the top (a), and the lateral nasal process is
to the right (l). Pax-7 is limited to the lateral nasal process.
(D) Similar preparation to (C) showing the trajectory of the nascent olfactory nerve (black arrows), labeled with NCAM. All olfactory axons
grow from the epithelium medially and then extend toward the anterior pole of the frontonasal mass.
(E) Coronal section through the frontonasal mass at E10.5 showing the relationship between NCAM-positive neurons and axons in the medial
epithelium and mesenchyme (fluorescein label), and Pax-7-positive mesenchymal cells in the lateral mesenchyme (rhodamine label). White
arrowheads indicate Pax-7 labeling in the lateral epithelium of the olfactory pit.
(F) Medial–lateral and anterior–posterior patterning occurs in vitro, based upon NCAM (blue) and Pax-7 (brown) labeling of epithelial cells,
axons, and mesenchyme. The white and black arrows indicate the medial–lateral boundary in the epithelium.
eye) embryos (Hill et al., 1991) where RA is not produced forebrain and frontonasal mass, while BMP4 is associ-
ated with the posterior aspect of the olfactory primordia.by the frontonasal mesenchyme (Anchan et al., 1997).
In Pax-6Sey/Pax-6Sey embryos that also carry one copy of
the bgeo6 transgene, bgeo6 cells are specifically absent RA Influences Lateral Differentiation
Based upon the local availability of RA, FGF8, shh, orfrom the frontonasal mass (Figures 4E and 4F). Together,
these results show that RA is a lateral signal whose the BMPs, it seemed likely that each of these signals
might help establish medial–lateral and anterior–pos-availability depends upon the position of neural crest–
associated cells in the frontonasal mass. terior distinctions in the developing olfactory pathway.
To evaluate this possibility, we altered local signalingWe then asked whether FGF8, shh, and BMP4 define
local signaling domains in the olfactory primordia. In the via RA (as well as FGF8, shh, or the BMPs; see below)
either by blocking its function or expanding its range offorebrain from E9.0 onward, FGF8 and shh mRNA is
restricted to a ventromedial domain (Figures 4G and action.
When the nonspecific alcohol dehydrogenase antago-4H). There are few, if any, RA-producing mesenchymal
cells immediately adjacent to this domain (Figure 4I). nist citral (which disrupts RA synthesis; Connor and
Smit, 1987; Marsh-Armstrong et al., 1994; Anchan et al.,FGF8, shh, and BMP4 cannot be detected in the surface
epithelium at E9.0. However, as the olfactory placode 1997) is introduced in epithelial/mesenchymal cultures,
differentiation is abolished and molecular markers arebegins to emerge, between E9.5 and E10.0, FGF8 is
seen in the medial epithelium of the frontonasal mass not seen in the remaining undifferentiated cell mass
(data not shown). As an alternative to this extreme ma-(Figure 4J and insert). At E10.5, after the olfactory epithe-
lium has invaginated, FGF8 is limited to a ridge of epithe- nipulation, we disrupted RA signaling using Pax-6Sey/
Pax-6Sey embryos that lack RA-producing frontonasallium in the medial nasal process (Figure 4L). shh is not
seen in the surface epithelium of the frontonasal mass mesenchymal cells. In these mutant embryos, there is
no olfactory epithelium, and b-tubulin, NCAM, Pax-7,at E9.5 (data not shown). By E10.5, however, shh is
expressed in the medial nasal process in a band of cells and RALDH-2 are not detected in the remaining surface
epithelium or mesenchyme (Figure 5, top row, and dataat the posterior and medial margin (Figure 4M). Finally,
from E9.5 onward, BMP4 is expressed in the epithelium not shown). E9.0 wild-type epithelium recombined with
mesenchyme from E9.0 Pax-6Sey homozygotes (geno-at the posterior boundary of the frontonasal mass and
prepalatal region (Figure 4K). At E10.5, BMP4 expression typed by PCR; data not shown) acquires some medial
characteristics: b-tubulin and NCAM are expressed incontinues to define the posterior aspects of the medial
and lateral nasal processes (Figure 4N). Thus, the ex- cells scattered throughout the epithelium. Nevertheless,
there is no clear medial–lateral axis, and Pax-7 is notpression patterns of FGF8 and shh suggest that these
molecules are associated with signaling from the medial seen (Figure 5, middle row). When Pax-6Sey homozygous
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Figure 4. Inductive Signals Are Associated with Medial–Lateral and Anterior–Posterior Axes in the Developing Olfactory Pathway
(A) An E9.5–E10 bgeo6 embryo shows that neural crest–associated cells are concentrated laterally (the position of the optic vesicle, ov,
indicates the oblique view).
(B) Top/front view of an E9.5–E10 DR5-RARE indicator embryo shows domains of RA-mediated gene expression.
(C) An explant of an E10 frontonasal mass, cocultured on a monolayer of RA-indicator cells, shows the lateral concentration of bgeo6-labeled
cells (arrows).
(D) In vivo fluorescence image of RA-activated, GFP-expressing indicator cells beneath the mesenchymal surface of the explant in (C).
Below (C) and (D) is a plot of b-gal- (blue) or GFP- (green) labeled cells showing registration of the two populations.
(E) bgeo6 cells in the lateral frontonasal mesenchyme (arrow) and other cranial neural crest targets of a normal E10.5 embryo.
(F) A Pax6Sey/Pax6Sey littermate shows the specific absence of bgeo6 cells from the frontonasal remnant (fnm?, arrow).
(G) A coronal section through an E9.0 embryo shows FGF8 mRNA restricted to the ventromedial forebrain. The frontonasal mesenchyme is
diminished in this region (arrow). The inset shows the distribution of FGF8 in the embryo from which this section was taken. The arrow
indicates the location of the section.
(H) At E9.0, shh is seen in the ventromedial forebrain (arrow).
(I) Coronal section through an E9.0 embryo shows bgeo6-labeled mesenchyme adjacent to the presumptive olfactory epithelium and attenuated
at the ventromedial forebrain (arrow).
(J) At E9.5, FGF8 mRNA is found in the epithelium of the presumptive nasomedial process (inset black box, arrows) and excluded from the
presumptive olfactory epithelium.
(K) BMP4 is expressed in the presumptive palatal epithelium (between arrows), posterior to the presumptive olfactory epithelium. In the inset,
the asterisk shows the approximate position of the presumptive olfactory epithelium.
(L) A dissected frontonasal process (oriented as indicated; anterior [a], lateral [l]) shows FGF8 expression at E10.5 maintained in the epithelial
ridge of the nasomedial process.
(M) At E10.5, shh is seen at the medial epithelial margin of the frontonasal process.
(N) At E10.5, BMP4 is seen in the posterior epithelium of the lateral and medial nasal processes.
epithelium is recombined with normal mesenchyme, lim- mutant epithelium does not respond to normal mesen-
chymal signals, nor can it maintain normal differentiationited b-tubulin expression is seen in a thickened epithelial
domain. NCAM is ectopically expressed in the mesen- of frontonasal mesenchyme.
In the presence of excess RA (1027 M), Pax-7 expres-chyme, but Pax-7 expression is not detected (Figure 5,
bottom row). Thus, the Pax-6Sey-dependent loss of RA sion expands in an apparent medial direction (Figure 6,
first row). To assess this change, we quantified Pax-7signaling from mesenchyme disrupts molecular differ-
entiation associated with the lateral but not medial olfac- expression in pairs of explants prepared from the same
embryo; one side is treated, and the other is the control.tory epithelium and mesenchyme. In contrast, Pax-6Sey
Induction of the Olfactory Pathway
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Figure 5. Medial Differentiation Persists
while Lateral Differentiation Fails when RA-Pro-
ducing Mesenchymal Cells Are Absent
First row: Front views of E10.5 Pax6Sey/Pax6Sey
embryos. Arrows indicate approximate loca-
tion of a remnant of the medionasal process;
asterisks indicate region where lateral nasal
process should be.
Second row: Recombination of normal epi-
thelium with Pax6Sey/Pax6Sey mesenchyme re-
sults in expression of neuronal (medial) mark-
ers b-tubulin and NCAM but not the lateral
mesenchymal marker Pax-7.
Third row: Recombination of Pax6Sey/Pax6Sey
epithelium with normal mesenchyme does
not fully restore molecular markers of axial or
neuronal differentiation.
The percent difference of Pax-7 label between these ithelial components of the developing olfactory pathway
and diminishes medial characteristics including neu-pairs has been compared to pairs in which both sides
ronal differentiation.remained untreated. In these pairs, an average of 57%
more of the mesenchyme is labeled by Pax-7 in the RA-
treated explant than in the untreated control explant as FGF8b Influences Medial Differentiation
compared to untreated explant pairs (p , 0.02; Figure When FGF8b signaling is blocked using a function-
7). There is no change in the overall size of the RA- blocking antibody (Dorkin et al., 1999), there is no signifi-
treated explants versus their untreated control side; cant change in explant size or epithelium size (Figure
however, the relative size of the epithelium increases 6, second row). There is, however, an expansion of Pax-7
by z30% in treated explants (p , 0.0002). The expansion expression that approximates that seen in RA-treated
of lateral mesenchyme and increase in proportion of explants (40% greater than control, p , 0.03; Figure 7).
epithelial area is accompanied by an apparent compres- This is accompanied by a reduction in the number of
sion of NCAM-positive cells in the medial aspect of the NCAM-labeled neurons in the presumptive epithelium,
epithelium. It is not possible to analyze this apparent also similar to that seen in RA-treated explants (Figure
change in the low magnification images shown in Figure 7). In contrast, FGF8b protein (100 ng/ml) leads to a 57%
6. Accordingly, we assessed the numbers of NCAM- increase in explant size and a corresponding increase
labeled cells throughout the entire depth of the olfactory in epithelial area (Figure 6, third row; p , 0.0001). In these
epithelium using differential interference contrast optics explants, the area of Pax-7 expression is diminished by
at higher magnification so that individual labeled cells 45% (p , 0.0002; Figure 7). NCAM-labeled cells are seen
could be clearly resolved and counted in all focal planes throughout the epithelial domain, rather than restricted
(Figure 7). There is an average 30% reduction in the to the medial region (Figure 7), and NCAM-labeled neu-
number of NCAM-positive cells compared to controls rites no longer form a coherent bundle at the lateral–
(p , 0.006; Figure 7). Thus, augmenting RA signaling medial interface (Figure 6). Finally, the number of NCAM-
labeled cells, imaged and quantified throughout theenhances lateral differentiation of mesenchymal and ep-
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Figure 6. RA, FGF8b, shh, noggin, and BMP4 Influence Axes, Morphogenesis, and Cellular Differentiation of the Olfactory Epithelium and
Nerve
At left: Pax-7 expression in explant pairs from the same embryo in which one side serves as an untreated control and the other has been
exposed to RA, anti-FGF8b, recombinant FGF8b, shh, noggin, or BMP4 protein.
At right: NCAM expression in explant pairs.
thickness of the epithelium, is increased by an average upon explant size, patterning, or cellular differentiation
(data not shown). In contrast, explants exposed to exog-of 85% (Figure 7). Thus, FGF8b enhances growth and
neuronal differentiation in the frontonasal mass in con- enous shh protein (100 ng/ml) are 33% larger (p , 0.002).
Despite this enhanced growth, there is no apparent shiftjunction with changes in medial epithelial and mesen-
chymal patterning as well as modifying the trajectory of of medial or lateral patterning (Figure 6, fourth row).
the nascent olfactory nerve. Pax-7 is expressed in a proportionally similar area in
shh-treated explants and controls, and there is no
change in the overall number of NCAM-labeled cellsShh Is a Growth Signal
Interfering with shh signaling using a function-blocking (Figure 7). Furthermore, NCAM-labeled neurites are fasi-
culated and follow a normal anterior trajectory. Theseantibody (Ericson et al., 1997) has no measurable effect
Induction of the Olfactory Pathway
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results suggest that shh acts as a general growth signal
in the olfactory primordia but does not seem to influence
patterning of the olfactory epithelium and nerve.
BMPs Influence Anterior–Posterior
and Neuronal Differentiation
When BMP signaling is inactivated in explant cultures
by noggin (an endogenous BMP antagonist; Zimmerman
et al., 1996), the entire frontonasal mesenchyme is lost
and only a small epithelial region remains (Figure 6, fifth
row; n 5 21/21 pairs). In this remnant, Pax-7 is not
detected (7/7 pairs); however, a patch of NCAM-positive
cells is seen (12/12 pairs). Processes from these cells
grow in a dense plexus around—but do not extend be-
yond—the perimeter of the explant. In contrast, BMP4
protein (20 ng/ml) decreases growth in frontonasal ex-
plants (Figure 6, sixth row) but leaves both mesenchymal
and epithelial components. In the mesenchyme, there
is a significant decrease in the area of Pax-7 expression
(23%, p , 0.004; Figure 7), and the remaining Pax-7
domain is often shifted into the lateral epithelium. The
number of NCAM-positive cells within the remaining epi-
thelium decreases (an average of 38% of control values,
p , 0.003; Figure 7) and a single, fasiculated olfactory
nerve is no longer seen. There are, however, ectopic
clusters of NCAM-expressing cells at the perimeter that
extend processes throughout the explant. Thus, the
BMPs provide posterior signals to influence the extent
of mesenchymal and dermal differentiation and may in-
fluence neural differentiation in the olfactory epithelium
via interaction with endogenous antagonists like noggin.
Discussion
Olfactory pathway development depends upon induc-
tion between frontonasal mesenchyme and adjacent ep-
Upper middle panel: A graph showing the mean percentage differ-
ence in Pax-7-labeled area for pairs of explants where inductive
signals have been manipulated for one of the pairs. The control
value represents explant pairs where both sides remained untreated.
For each graph, n 5 number of pairs analyzed. Two-tailed t tests
were performed, and asterisks indicate mean values that are signifi-
cantly different from the control pairs (p , 0.05; individual values
in text).
Middle panel: A pair of explants showing the method for identifying
and counting NCAM-labeled cells in the presumptive olfactory epi-
thelium and the effects of RA treatment. Each panel shows a single
focal plane from the full through-focus series. Arrows indicate exam-
ples of cells that would be counted in each. Two representative cells
that meet the criteria for counting (see Experimental Procedures)
are shown in the inset at right. The nuclei are labeled (n), and the
arrowheads indicate a process emerging from each cell. The totalFigure 7. Quantitative Changes in Patterning and Cellular Differenti-
number of cells in this example (obtained from the completeation in Response to Manipulating RA, FGF8b, shh, and BMP4 Sig-
through-focus series) is 47 for the control, and 19 for the RA-treatednaling
explant.
Upper panel: A pair of explants showing the method for measuring Lower middle panel: A pair of explants showing the effects of FGF8b
Pax-7-labeled area (see Experimental Procedures for a complete treatment on the number and distribution of NCAM-labeled cells.
explanation). The thick dotted line indicates the perimeter of the NCAM-labeled cells are seen throughout the presumptive olfactory
explant, which represents the total explant area (values in black), epithelium in the treated explant, rather than limited to the medial
and the thin dotted line defines the perimeter of the Pax-7-labeled portion as in the control. The total number of cells in this example
domain (values in white). The percentage of Pax-7 area for each (obtained from the complete through-focus series) is 53 for the
explant was calculated by dividing the Pax-7 area by the total area. control and 77 for the FGF8b-treated explant.
For the examples shown here, the control value is 35.7%, and the Lower panel: A graph showing the percentage difference of NCAM-
RA-treated value is 53.8%. Accordingly, the mean percentage differ- positive cells in the presumptive olfactory epithelium for the control
ence for this explant pair is 151%. versus treated side.
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ithelia. As at other sites of mesenchymal/epithelial in- duction contributes to morphogenesis of the olfactory
bulb.duction—especially the limbs, the branchial arches, and
the aortic arches of the heart—the local actions of sev-
eral signaling molecules contribute to distinct facets of Neural Crest and Mesenchymal/Epithelial
this process. No single molecule, however, is uniquely Induction in the Olfactory Pathway
responsible for morphogenesis and cellular differentia- Neural crest–associated mesenchymal cells define a lo-
tion in the olfactory pathway. Instead, when frontonasal cal source of RA in the lateral frontonasal mesenchyme,
mesenchymal/epithelial signaling is disrupted—by phys- and olfactory pathway development is disrupted when
ical separation, by mutation, or by manipulation of sig- this signal is absent. Recent analysis of cranial neural
naling molecules—specific aspects of patterning and crest migration, cell death, and cell fate suggests a sys-
differentiation are compromised. The deficits reflect nor- tematic relationship between neural crest–associated
mal axial and cellular differentiation that accompanies structures in the head and their origin or migration from
mesenchymal/epithelial induction. Thus, the initial dif- specific locations in the hindbrain and midbrain (Serbe-
ferentiation of the olfactory pathway relies upon a mech- dzija et al., 1992; Sechrist et al., 1993; Graham et al.,
anism shared by the limbs, branchial arches, and heart 1994). The frontonasal mesenchymal cells described
that has been adapted for neural development in a func- here probably originate from anterior mesencephalic
tionally distinct forebrain pathway. levels of the neural tube and have a specific migratory
path (Serbedzija et al., 1992; Osumi-Yamashita et al.,
1994). Thus, the origin and migration of neural crest cellsInduction and Olfactory Pathway Development
may help specify mesenchymal/epithelial induction inMesenchymal/epithelial induction, in vitro, leads to a
the olfactory pathway. There may be a similar relation-nearly complete spectrum of differentiated cells and
ship between origin and inductive capacity of neuralstructures in the embryonic olfactory epithelium and
crest in branchial arches (Lumsden, 1988; O’Connor andnerve (Cuschieri and Bannister, 1975; Miragall et al.,
Tessier-Lavigne, 1999), aortic arches (Le Lievre and Le1989; Whitesides and LaMantia, 1996). Our results sug-
Dourain, 1975; Waldo et al., 1996; Creazzo et al., 1998),gest that initial neural differentiation of the surface ecto-
and limb buds (Shoobridge et al., 1983; Ros et al., 1997;derm to olfactory epithelium may rely upon BMP antago-
Patapoutian et al., 1999). It is therefore possible that thenists like noggin, perhaps in conjunction with FGF
origin of neural crest along the anterior–posterior axissignals, as is the case for other neuralized regions of
helps to specify several sites of nonaxial mesenchymal/the ectoderm (Lamb and Harland, 1995; Bachiller et al.,
epithelial induction including the olfactory pathway.2000). Furthermore, the initial differentiation of NCAM-
positive neurons in the medial olfactory epithelium and
Induction, the Pax-6Sey Mutation, and Olfactorythe initial trajectory of their axons depends upon medial–
Pathway Developmentlateral and anterior–posterior patterning in both the epi-
Neither mesenchyme nor epithelium from Pax-6Sey ho-thelium and mesenchyme. This may reflect the activity
mozygous mutant embryos completely supports the de-of FGF8b on the medial mesenchyme; however, it is
velopment of an olfactory epithelium and nerve whenunlikely that FGF8 acts directly on the epithelial cells to
recombined with their wild-type counterparts. Accord-elicit neuronal differentiation (De Hamer et al., 1994).
ingly, prior to E9.0, Pax-6 must confer competence uponFinally, axon fasiculation and directed outgrowth of the
both tissues for inductive interactions that mediate ol-olfactory nerve are similar to that in the embryo, where
factory pathway development. The loss of competencethe forebrain is present (Whitesides and LaMantia,
in homozygous mutant tissues might be due to the activ-1996). This implies that there is little target-derived guid-
ity of mutant Pax-6 in the facial epithelium or dorsalance from the forebrain for the initial projection of the
forebrain (Grindley et al., 1995). Nevertheless, it alsoolfactory nerve. Instead, the initial growth of the olfac-
reflects the compromised state of the frontonasal mes-tory nerve is influenced by the concerted action of sig-
enchyme, which lacks neural crest due to a deficit innals like RA, FGF8, and the BMPs from the local sources
the migratory pathway (Matsuo et al., 1993; Osumi-within the frontonasal process.
Yamashita et al., 1997) and which does not produce atMesenchymal/epithelial induction may influence the
least one signal, RA (Anchan et al., 1997). In the embryoinitial formation of the olfactory bulb. The frontonasal
and in recombined cultures with mutant mesenchymemesenchyme is also apposed to the ventrolateral fore-
or epithelium, lateral structures and expression of lateralbrain and at least one mesenchymal signal, RA, acti-
markers in the olfactory pathway seem to be absent andvates gene expression in the ventrolateral forebrain (La-
corresponding medial differentiation is aberrant. Thus,Mantia et al., 1993; Whitesides and LaMantia, 1996;
the Pax-6 mutation compromises mesenchymal/epithe-Anchan et al., 1997). Furthermore, RA teratogenesis, shh
lial signaling, including local RA signaling, that is essen-inactivation, and the Pax-6 mutation compromises the
tial for the initial differentiation of the olfactory epithe-olfactory bulb as well as the epithelium and nerve
lium and nerve.(Chiang et al., 1996; Anchan et al., 1997; Dellovade et
al., 1998). Finally, olfactory axons are not necessary
for bulb morphogenesis in embryologically manipulated Axes, Signals, and Olfactory Pathway Induction
At the best-studied site of mesenchymal/epithelial inter-frogs or Emx-2 mutant mice (Byrd and Burd, 1993; Yo-
shida et al., 1997). It is more likely that the axons influ- action—the limb bud (reviewed by Tickle and Eichele,
1994; Johnson and Tabin 1997)—the induction of axesence later stages of bulb development (Stout and Grazi-
adei, 1980; Gong and Shipley, 1995). Together, these based upon local signals is an essential first step in
guiding subsequent morphogenesis and cellular differ-observations suggest that mesenchymal/epithelial in-
Induction of the Olfactory Pathway
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Figure 8. A Schematic of Axes and Signals
that Influence Mesenchymal/Epithelial Induc-
tion in the Olfactory Pathway
Each drawing represents a section through
the forebrain at the age indicated. The dorsal
(d), posterior (p), and lateral (l) axes for each
drawing are indicated at the bottom, left. The
sources of four inductive signals commonly
associated with mesenchymal/epithelial in-
teractions are indicated diagrammatically,
based upon the localization data in the text.
The arrows associated with each local signal-
ing source indicate our interpretation of the
general direction in which these signals act
in ongoing mesenchymal/epithelial interac-
tions. These interpretations are based upon
the results of the gain- and loss-of-function
experiments that disrupt aspects of gene ex-
pression, morphogenesis, or cellular differen-
tiation associated primarily with the lateral,
medial, anterior, or posterior axes in the de-
veloping frontonasal mass.
entiation. Early embryological studies (Balinsky, 1933; mesenchymal patterning, neuronal differentiation, or the
growth of the olfactory nerve.reviewed by Slack, 1995) indicate that the olfactory pri-
mordia, when transplanted beneath flank ectoderm, can The four signals that we have examined do not by
themselves account for olfactory pathway development,induce a limb. This observation raises the possibility
that the frontonasal epithelium and mesenchyme shares nor do they reflect the singular and direct effects of any
of the four molecules on a specific cell type. Instead,significant inductive capacity with the limb; however,
this possibility has never been explored. We have shown they are common components of a molecular process
for mesenchymal/epithelial interaction. In limbs, bran-that mesenchymal/epithelial induction mediated by lo-
cal molecular signals also found in the limb establishes chial arches, and heart, altering RA, shh, the FGFs, or
the BMPs disrupts axis formation and correspondingaxial coordinates for the developing olfactory pathway.
Furthermore, these axes constrain neuronal differentia- morphogenesis (Helms et al., 1997; Johnson and Tabin,
1997; Neubu¨ser et al., 1997; Barlow et al., 1999; Trumpption in the olfactory epithelium and the trajectory of
axons in the olfactory nerve. Thus, the cellular mecha- et al., 1999). At these sites, it is not possible to determine
whether these signals act solely on mesenchyme ornisms and morphogenetic consequences of mesenchy-
mal/epithelial induction in the olfactory pathway are epithelium; nor can one assign any singular facet of
cellular differentiation to a single signal. Similarly, it isanalogous to those in the limb.
These axial constraints for olfactory pathway develop- not possible to assign the effects of RA, FGF8, shh, and
BMP4 to any one cellular target in the olfactory pathway.ment provide a valuable framework for evaluating the
contribution of several individual signals. RA, FGFs, shh, Their concerted local action on subsets of mesenchymal
and epithelial cells and subsequent additional signalingand BMPs have all been implicated in olfactory develop-
ment (Shenefelt, 1972; LaMantia et al., 1993; De Hamer between these cells combine to elicit differentiation of
olfactory neurons as well as the epithelial and skeletalet al., 1994; Chiang et al., 1996; Lanoue et al., 1999;
Shou et al., 1999). However, previous teratogenic, ge- elements in the frontonasal process.
We have analyzed the role of induction and inductivenetic, and pharmacological studies have not fully de-
fined the endogenous contribution of each molecule signals in the developing olfactory pathway primarily in
an in vitro assay system. This approach permits greaterto neuronal and nonneuronal differentiation. Our data
shows that within the context of ongoing mesenchymal/ physical access to the principle embryonic tissues that
participate in induction and simplifies the manipula-epithelial interactions, each signal is associated with a
single axis: RA is a lateral signal, FGF8 and shh are tion of specific signals. Nevertheless, this system as
well similar assays that have been used to examinemedial signals, and BMP4 is a posterior signal (Figure
8). The normal localization of each molecule supports mesenchymal/epithelial interactions in the mammalian
branchial arches and limb buds (Neubu¨ser et al., 1997;these conclusions and the results of manipulating these
signals are consistent with specific axial functions. Weston et al., 2000) have some limitations. First, any
distal signals, beyond the surface epithelium and adja-When signaling via any one is disrupted, either by
blocking or augmenting its function, there are consistent cent mesenchyme, are eliminated from the sequence of
interactions that lead to morphogenesis and develop-and predictable changes in morphogenesis, gene ex-
pression, and cellular differentiation. These changes fo- ment. Second, molecular manipulations done in vitro
are often more effective in disrupting rather than aug-cus upon a single axial direction with consequences for
Neuron
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NCAM (Chemicon) and mouse monoclonal a-Pax-7. Video imagesmenting developmental processes. Third, in vitro assays
were obtained using a Leica epifluorescence microscope.are limited in the epoch of development that can be
examined. Accordingly, our in vitro results provide an
Explant Cocultures for RA Productionoutline of the cellular and molecular interactions that
Cocultures of the E10 frontonasal mass (mesenchyme plus olfactoryaccompany a distinct period of early olfactory pathway
epithelium) and monolayers of RA-indicator cells were prepared as
morphogenesis. They do not, however, fully define the described previously (Colbert et al., 1993; LaMantia et al., 1993). A
mechanisms that operate in vivo to direct specific cells novel RA-sensitive cell line (the CE6 line) was clonally derived after
and tissues to their final differentiated state in the intact transfecting mouse L cells with a DR5-RARE-thymidine kinase pro-
moter driving a GFP reporter (GIBCO Green Lantern, GIBCO–BRL).olfactory system.
The cell line was assessed for RA responses to 10210 to 1024 M
all-trans RA. Cocultures of CE6 cell monolayers with frontonasal
Induction, Peripheral Malformations, and Disrupted mesenchyme (and overlying epithelium) were imaged live using an
Forebrain Development inverted microscope. Images of GFP signal were collected, the ori-
entation of the live explant was recorded by a brightfield image,Limb, heart, face, and forebrain development can be
and then the explants were prepared for b-gal histochemistry. b-gal-disrupted by common teratogens, including RA as well
labeled preparations and matching GFP images were aligned byas compounds or mutations that alter FGF, shh, or BMP
eye, using the image of the unfixed explant as a guide, and cells
signaling (Sulik and Sadler, 1993; Cooper et al., 1998; were plotted using video overlay software.
Meyers et al., 1998; Golden et al., 1999). Furthermore,
clinical disorders that involve forebrain dysfunction are
In Situ Hybridization
often correlated with limb, heart, and face malformations Antisense RNA probes for shh, FGF8, and BMP4 were synthesized
(reviewed by Waddington, 1993; LaMantia, 1999). Ge- using plasmids containing either fragments or complete cDNAs (shh
netic studies of patients with these disorders have linked provided by A. McMahon; FGF8 by G. Martin; BMP4 by T. Michael
Underhill). In situ hybridizations were performed using establishedchromosomal deletions in loci that include inductive sig-
protocols for whole embryos (Belo et al., 1997). Hybridized embryosnals or patterning genes with vulnerability to a variety
were postfixed, embedded, and photographed, and then preparedof behavioral and psychiatric diseases (reviewed by
for cryomicrotomy. Sections were imaged using differential interfer-
Driscoll and Emanuel, 1996; Goodman, 1998; LaMantia, ence contrast optics.
1999). Parallel studies of homologous genes in the
mouse suggest that some genes from these loci may Mesenchyme/Epithelium Cocultures
be preferentially expressed at sites of mesenchymal/ The frontonasal mass including the forebrain neuroepithelium was
epithelial induction, including the forebrain (Wilming et dissected from E9.0 embryos. This trilaminar piece was transferred
to 2.5% pancreatin/0.25% trypsin in L15 media for at least 30 minal., 1997; Lindsay et al., 1999; Yamagishi et al., 1999).
on ice (Neubu¨ser et al., 1997). The tissue was then transferred toWe conclude that peripheral malformations and brain
L15 media with 10% steroid-retinoid-depleted horse serum anddysfunction in teratogenized or mutant individuals might
each layer separated using sharpened tungsten microneedles.
reflect, in part, the disruption of a common inductive These pieces were cultured separately or recombined on 8 mm
mechanism mediated by shared signals and related nucleopore filter circles floating on 3 ml DMEM/10% steroid-reti-
genes in the limbs, heart, face, and forebrain. noid-stripped fetal bovine serum at 378C in 95% room air/5% CO2
for 48 hr. For manipulating signaling, all-trans RA (Sigma) was han-
dled in yellow light and added to obtain a final concentration of 1027Experimental Procedures
M. Recombinant mouse FGF8b and shh protein or recombinant
human BMP4 protein (R&D Systems) was added at concentrationsMice
of 100 ng/ml (mFGF8b and mshh) or 20 ng/ml (hBMP4). FunctionWild-type (CF-1, Charles River Labs; ICR, Harlan), transgenic, and
blocking antibodies against FGF8b (R&D Systems) or shh (Develop-mutant/transgenic embryos were obtained from timed pregnancies
mental Studies Hybridoma Bank) were added at 1.0 mg/ml and 5.0(morning after breeding 5 E0.5) generated in a breeding colony
mg, respectively. CHO cells transfected with a Xenopus noggin ex-maintained by the Department of Laboratory Animal Medicine at
pression construct as well as the parental CHO line (Lamb et al.,University of North Carolina at Chapel Hill. Pregnant mice were killed
1993; kindly provided by Drs. R. Harland and J. M. DeJesus) wereby cervical dislocation and embryos harvested immediately. The
grown to z50% confluence in 3 ml of aMEM in 35 mm dishes forbgeo6 gene-trap line was generated by random insertion of a tar-
2 days. Freshly prepared explants were transferred directly to thesegeting vector in embryonic stem cells (Friedrich and Soriano, 1991).
dishes and cultured for another 48 hr. All cultures were imaged liveThe presence of transgenes (in breeding males only) was confirmed
and then fixed for immunohistochemistry.by PCR of genomic DNA. Pax6Sey homozygotes and littermates were
PCR genotyped as described by Hill et al. (1991).
Quantification of Area of Pax-7 Expression and Number
of NCAM-Labeled CellsHistochemistry and Immunocytochemistry
b-gal histochemistry was performed using established protocols Images were obtained of 49 Pax-7-labeled explant pairs from 98
individual embryos at an onscreen magnification of 163 with stan-(LaMantia et al., 1993). For whole immunostained preparations,
nickel chloride (0.05%) was used with diamino benzidine (DAB) to dard illumination on a Leica photomacroscope. Total area was mea-
sured by tracing the perimeter of each explant using NIH Imageenhance detection of HRP-conjugated secondary antibodies. For
double labeling, alkaline phosphatase was used with bromo chloro software. The Pax-7-labeled domain was defined as the area of
contiguous Pax-7 immunoreactivity where cells with clearly labeledindole phosphate (BCIP) to give a blue reaction product, and HRP
was used with DAB to give a brown reaction product. Specimens nuclei (where Pax-7 is expressed) are seen. In all explants there is an
area of lighter Pax-7 immunoreactivity in the presumptive olfactorywere labeled using rat monoclonal a-NCAM (Chemicon), mouse
monoclonal a-b-tubulin (Babco), a-Pax-7 (SEI; Developmental Stud- epithelium. This region was included in the area measurements;
however, the percentage differences between control and experi-ies Hybridoma Bank), and a rabbit RALDH2 antiserum (P. McCaf-
fery). These preparations were video imaged on a Leica photomac- mental sides do not change if only mesenchymal Pax-7 is measured.
The percentage of Pax-7-labeled area was calculated by dividingroscope. For double fluorescent labeling, 15 mm cryostat sections
were incubated sequentially with rabbit a-b-gal (J. Sanes) followed the Pax-7-labeled area by the total explant area. These values were
compared only within sets of explants from individual embryos. Forby a mouse monoclonal a-nestin (RAT401; Developmental Studies
Hybridoma Bank) or a-GAP43 (P. Skene); or rabbit polyclonal anti- each treatment, the mean percentage difference of the explant pairs
Induction of the Olfactory Pathway
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was calculated and then compared with that of pairs where neither evaluation of olfactory bulb development in Xenopus after olfactory
placode transplantation. J. Comp. Neurol. 331, 551–563.side was exposed to inductive signals or antagonists.
To count NCAM-labeled cells, 37 pairs of explants from 64 individ- Calof, A.L., and Chikaraishi, D.M. (1989). Analysis of neurogenesis
ual embryos were imaged using differential interference contrast in a mammalian neuroepithelium: proliferation and differentiation of
optics at an onscreen magnfication of 2303 with a Hammatsu ORCA an olfactory neuron precursor in vitro. Neuron 3, 115–127.
video camera on a Leica DMR microscope. The outline of the epithe-
Chiang, C., Litingtung, Y., Lee, E., Young, K.E., Corden, J.L., West-lium was determined, and the depth of the initial focal plane where
phal, H., and Beachy, P.A. (1996). Cyclopia and defective axial pat-NCAM-labeled cells could be seen was established using a z axis
terning in mice lacking Sonic hedgehog gene function. Nature 383,micrometer. NCAM-labeled cells were identified based upon the
407–413.following criteria: each cell has a visible nucleus surrounded by
Colbert, M.C., Linney, E., and LaMantia, A.-S. (1993). Local sourcesNCAM-labeled cytoplasm and an apical or basal extension. Such
of retinoic acid coincide with retinoid-mediated transgene activitycells were counted by overlaying a counting mark in a separate
during embryonic development. Proc. Natl. Acad. Sci. USA 90, 6572–video layer; then the objective was advanced to a focal plane 10
6576.mm deeper. By focusing back to the previous layer, previously
counted cells were excluded and labeled cells in the relevant focal Connor, M., and Smit, M.H. (1987). Terminal-group oxidation of reti-
plane were counted. This was repeated until an entire through-focus nol by mouse epidermis: inhibition in vitro and in vivo. Biochem. J.
series was obtained and all cells were counted. For each explant 244, 489–492.
pair, the percentage difference was calculated by dividing the num- Cooper, M.K., Porter, J.A., Young, K.E., and Beachy, P.A. (1998).
ber of NCAM-labeled cells in the treated explant by that in the Teratogen-mediated inhibition of target tissue response to Shh sig-
untreated control. The mean percentage difference was then calcu- naling. Science 280, 1603–1607.
lated for each individual treatment group and compared statistically
Creazzo, T.L., Godt, R.E., Leatherbury, L., Conway, S.J., and Kirby,with that from pairs of untreated explants.
M.L. (1998). Role of cardiac neural crest cells in cardiovascular
development. Annu. Rev. Physiol. 60, 267–286.
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